US CDC: Most Booster Shot Side Effects Are Mild
[Asia Economy Reporter Cho Hyun-ui] Adverse reactions to booster shots in the United States were mostly mild, such as arm pain and fatigue.
The U.S. Centers for Disease Control and Prevention (CDC) released analysis data on the 22,191 people who voluntarily reported adverse reactions among those who received a booster shot after completing their second dose from last month 12th to this month 19th (local time) on the 28th.
Pain at the injection site was the most common at 71%, followed by fatigue (56%) and headache (43%). The number of people hospitalized after vaccination was 13, but the reasons for hospitalization were not confirmed in the survey.
Except for fewer than 200 people who received the first dose with the Janssen vaccine or the booster shot, about 99% of the reporters received their third dose with the mRNA (Pfizer·Moderna) vaccine, which was used for the second dose.
The reports were made within 7 days from the day of the booster shot vaccination.
Meanwhile, among the 12,591 people who completed the health check survey, the rates of local and systemic reactions were 79.4% and 74.1%, respectively, which were not significantly different from the reaction reporting rates after the second dose (77.6%, 76.5%).
Based on this, the CDC stated, "This shows that the occurrence of adverse reactions after the booster shot is within the expected range."
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Rochelle Walensky, CDC Director, explained, "The types and frequency of reported adverse reactions are similar to those after the second dose," adding, "Most were mild and did not last long."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.